Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Nation

Showing results (131-140 of 247) with videos related to

Pageof 25
Sort By:
The Journal of Antimicrobial Chemotherapy|November 8, 2014
Imaging the distribution of polymyxins in the kidneyBo Yun, Mohammad A K Azad, Jiping Wang, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2023
Correction for Antachopoulos et al., "Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher than Recommended Doses"Charalampos Antachopoulos, Anastasia Geladari, Cornelia B Landersdorfer, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Critical Need for Clarity in Polymyxin B DosingNikolas J Onufrak, Gauri G Rao, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2021
Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher Than Recommended DosesCharalampos Antachopoulos, Anastasia Geladari, Cornelia B Landersdorfer, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 2010
Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatmentRachel L Soon, Roger L Nation, Stewart Cockram, et al.
ACS Infectious Diseases|August 16, 2016
Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative BacteriaKade D Roberts, Mohammad A K Azad, Jiping Wang, et al.
Journal of Lipids|January 15, 2013
Molecular Characterization of Lipopolysaccharide Binding to Human α-1-Acid GlycoproteinJohnny X Huang, Mohammad A K Azad, Elizabeth Yuriev, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill PatientsAlan Forrest, Samira M Garonzik, Visanu Thamlikitkul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Reply to Corona and CattaneoRoger L Nation, Samira M Garonzik, Visanu Thamlikitkul, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2010
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membraneMartti Vaara, Osmo Siikanen, Juha Apajalahti, et al.
Pageof 25

Showing results (131-140 of 247) with videos related to

Sort By:
Pageof 25
The Journal of Antimicrobial Chemotherapy|November 8, 2014
Imaging the distribution of polymyxins in the kidneyBo Yun, Mohammad A K Azad, Jiping Wang, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2023
Correction for Antachopoulos et al., "Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher than Recommended Doses"Charalampos Antachopoulos, Anastasia Geladari, Cornelia B Landersdorfer, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Critical Need for Clarity in Polymyxin B DosingNikolas J Onufrak, Gauri G Rao, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2021
Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher Than Recommended DosesCharalampos Antachopoulos, Anastasia Geladari, Cornelia B Landersdorfer, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 2010
Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatmentRachel L Soon, Roger L Nation, Stewart Cockram, et al.
ACS Infectious Diseases|August 16, 2016
Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative BacteriaKade D Roberts, Mohammad A K Azad, Jiping Wang, et al.
Journal of Lipids|January 15, 2013
Molecular Characterization of Lipopolysaccharide Binding to Human α-1-Acid GlycoproteinJohnny X Huang, Mohammad A K Azad, Elizabeth Yuriev, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill PatientsAlan Forrest, Samira M Garonzik, Visanu Thamlikitkul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Reply to Corona and CattaneoRoger L Nation, Samira M Garonzik, Visanu Thamlikitkul, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2010
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membraneMartti Vaara, Osmo Siikanen, Juha Apajalahti, et al.
Pageof 25